C-ABL-IN-5
Product Specifications
Target
Bcr-Abl
Related Pathways
Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling|||Angiogenesis
Bioactivity
C-ABL-IN-5, a selective c-Abl inhibitor, exhibits neuroprotective properties and has favorable characteristics including blood-brain barrier permeability, metabolic stability, and pharmacokinetic profiles. When labeled with [18F] (compound [18F]3), C-ABL-IN-5 serves as a tracer in positron emission tomography (PET) scans to assess disease-modifying effects, particularly in research on neurodegenerative conditions like Parkinson's disease (PD) [1].
Molecular Formula
C19H17F2N3O
Molecular Weight
341.35
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1397572-01 0.02 mg (E-Coli)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details MBS1397572-02 0.1 mg (E-Coli)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details 
MBS1397572-03 0.02 mg (Yeast)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details 
MBS1397572-04 0.1 mg (Yeast)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details 
MBS1397572-05 0.02 mg (Baculovirus)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details MBS1397572-06 0.02 mg (Mammalian-Cell)
Recombinant Bovine V-type proton ATPase subunit E 2 (ATP6V1E2)
Ask
View Details